The primary objective is to investigate the potential ability of Inderal (propranolol hydrochloride) to diminish the reconsolidation of motivationally potent drug-related cues in cocaine dependent participants. If effective in this laboratory model, Inderal may have clinical efficacy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
60
Inderal vs. placebo will be administered with or without cocaine cues
Self-report drug craving
One day and one month after the intervention, the investigators will measure drug craving using visual analog scales (VAS) and the Cocaine Craving Questionnaire (CCQ).
Time frame: One day and one month post-treatment
Drug use
One month after the intervention, participants will be interviewed about their drug and alcohol use
Time frame: One month after the intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.